MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
-14.83%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$335M
AUM Growth
+$335M
(-25%)
Cap. Flow
-$52.6M
Cap. Flow
% of AUM
-15.7%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $180M | 53.77% | 19,963,157 | – | – |
|
2
Phathom Pharmaceuticals
PHAT
$864M
| $76.9M | 22.93% | 7,464,572 | – | – |
|
3
NewAmsterdam Pharma
NAMS
$2.71B
| $55.1M | 16.44% | 2,869,565 | – | – |
|
4
Aura Biosciences
AURA
$389M
| $23M | 6.85% | 3,039,892 | – | – |
|
5
Merus
MRUS
$4.98B
| – | – | -1,169,028 | Closed | -$52.6M |
|